Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression

Heart

Volumn 77, Issue 1, 1997, Pages 62-67

  Caforio, Alida L P ^a,b   Goldman, Jonathan H ^a   Baig, Mirza K ^a   Haven, Aldwyn J ^a   Dalla Libera, Luciano ^b   Keeling, Philip J ^a   McKenna, William J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

anti myosin antibodies; autoimmune disease; cardiac specific antibodies; idiopathic dilated cardiomyopathy

Indexed keywords

AUTOANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; CARDIOMYOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 0031046138     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.77.1.62     Document Type: Article

References (30)

1. Brandenburg RO, Chazov E, Cherian G, Falase AO, Grosgogeat Y, Kawai C, et al. Report of the WHO/ISFC task force on definition and classification of the cardiomyopathies. Circulation 1981;64:437A-8A.
2. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow D, Michels VV, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol 1992;69:1458-66.
3. Limas CJ, Goldenberg IF, Limas C. Autoantibodies against β-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989;64:97-103.
4. 1 adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990;86:1658-63.
5. Klein R, Maisch B, Kochsiek K, Berg PA. Demonstration of organ-specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol 1984;58:283-92.
6. Schultheiss HP, Bolte HD. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol 1985; 17:603-17.
7. Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983;52: 1072-8.
8. Caforio ALP, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, et al. Novel organ-specific cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990;15:1527-34.
9. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990;16:839-46.
10. Caforio ALP, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, et al. Identification of the α and β myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992;85:1734-42.
11. Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J Am Coll Cardiol 1993;22:1378-84.
12. Goldman JH, Keeling PJ, Warraich RS, Redwood S, Baig KM, Elliott PM, et al. Autoimmunity to α-myosin in a subset of patients with idiopathic dilated cardiomyopathy. Br Heart J 1995;74:598-603.
13. Caforio ALP, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, et al. Autoimmunity in dilated cardiomyopathy: evidence from family studies. Lancet 1994;344: 773-7.
14. Caforio ALP. Role of autoimmunity in dilated cardiomyopathy. Br Heart J 1994;72 (suppl):S30-4.
15. Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D. Complement-fixing islet-cell antibodies in Type-I diabetes: possible monitors of active β-cell damage. Lancet 1980;i:668-72.
16. Bottazzo GF. On the honey disease. A dialogue with Socrates. Diabetes 1993;42:778-800.
17. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg AO, Frye RL. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-31.
18. Blackie SP, Fairbarn MS, MCelvaney GN, Morrison NJ, Wilcox PG, Pardy RL. Prediction of maximal oxygen uptake and power during cycle ergometry in subjects older than 55 years of age. Am Rev Respir Dis 1989;139: 1424-9.
19. Aretz HT, Billingham ME, Edwards WE, Factor S, Fallon J, Fenoglio J Jr, et al. Myocarditis: a histopathological definition and classification. Am J Cardiol Pathol 1985;1:1-10.
20. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, et al. Quantitation of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990;335:147-9.
21. Bottazzo GF, Todd I, Mirakian R, Belfiore A, Pujol-Borrell R. Organ-specific autoimmunity. A 1986 overview. Immunol Rev 1986;94:137-69.
22. Rose NR, Bona C. Defining criteria for autoimmune disease (Witebsky's postulates revisited). Immunol Today 1991;14:426-8.
23. Caforio ALP, Martinetti M, Bonifacio E, Gavazzi A, Graziano G, Cuccia MC, et al. Idiopathic dilated cardiomyopathy: lack of association between organ-specific cardiac antibodies and HLA-DR antigens. Tissue Antigens 1992;39:236-40.
24. Bilinska ZT, Caforio ALP, Grzybowski J, Michalak E, Kusmierczyc-Droszcz B, Goldman JH, et al. Organ-specific cardiac autoantibodies in dilated cardiomyopathy: frequency and clinical correlates in Polish patients. Eur Heart J 1995;16:1907-11.
25. Kaplan MH, Frengley DJ. Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, post-cardiotomy and post infarction syndromes and cardiomyopathies. Am J Cardiol 1969;24:459-73.
26. Maisch B, Berg PA, Kochsiek K. Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I Relevance of antibody pattern. Clin Exp Immunol 1979;38:189-97.
27. Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol 1994;23:146-53.
28. De Scheerder IK, De Buyzere M, De Langhe J, Maas A, Clement DL, Wieme R. Humoral immune response against contractile proteins (actin and myosin) during cardiovascular disease. Eur Heart J 1991;12:88-94.
29. Frennaux MP, Counihan PJ, Caforio ALP, Chikamori T, McKenna WJ. Abnormal blood pressure response in hypertrophic cardiomyopathy. Circulation 1990;82: 1995-2002.
30. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine BT, et al. Task force 3: Recipient guidelines/prioritization. J Am Coll Cardiol 1993;22: 21-30.